Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis-Reference-Cited by-同舟云学术

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis

Published:2016-06-03 Issue:12 Volume:88 Page:6317-6325
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Mills John R.¹,Cornec Divi²³,Dasari Surendra⁴,Ladwig Paula M.¹,Hummel Amber M.²,Cheu Melissa⁵,Murray David L.¹,Willrich Maria A.¹,Snyder Melissa R.¹,Hoffman Gary S.⁶,Kallenberg Cees G. M.⁷,Langford Carol A.⁶,Merkel Peter A.⁸,Monach Paul A.⁹,Seo Philip¹⁰,Spiera Robert F.¹¹,St. Clair E. William¹²,Stone John H.¹³,Specks Ulrich²,Barnidge David R.¹

Affiliation:

1. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, United States

2. Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota 55905, United States

3. Rheumatology Department, Brest University Hospital, 29609 Brest, Cedex, France

4. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, United States

5. Genentech Inc., South San Francisco, California 94080, United States

6. Cleveland Clinic Foundation, Cleveland, Ohio 44195, United States

7. University of Groningen, 9712 CP Groningen, The Netherlands

8. University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

9. Boston University Medical Center, Boston, Massachusetts 02115, United States

10. Johns Hopkins University, Baltimore, Maryland 21218, United States

11. Hospital for Special Surgery, New York, New York 10021, United States